Amneal Aims To Bolster Generics Margins
As Company Aims To Deliver Six To Seven High-Value Products Annually
Amneal says it is taking initiatives to improve its generics margins by improving its manufacturing and supply chain, after its generics segment was sales drop by 11% in the first quarter. Amneal is aiming to deliver six to seven high-value products annually, while the company is also looking to launch three biosimilars in the next couple of years.
